Table 3.

Half year, 1-and 2-year survival rate of OS.

Overall Survival Rates (%)	6-month	1-year	2-year
Immunotherapy	97.0%	78.9%	22.1%
Non-immunotherapy	83.7%	56.5%	10.4%